ECVs from PD173074-treated +/+ stroma or -/- stroma were not as protective, suggesting that Fgf2 +/+ stroma more effectively protects BCR-ABL leukemia cells from the effects of kinase inhibition through secretion of protective exosomes. This evidence concerns the gene FGF2 and leukemia.